Concepedia

P. Farahmand

PF

Statistics

Publications

11

Citations

672

H-Index

10

Active since

1998

Affiliations

Klinikum Leverkusen(Current)

University of Cologne

Bellvitge University Hospital

University Hospital Schleswig-Holstein

IPPMed (Germany)

P. Farahmand is an author at Klinikum Leverkusen specializing in medicine, osteoporosis pharmacotherapy, and bone metabolism.

Publications per year

1998–2015

11

Publications

11

Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial

Claus‐C. Glüer, Fernando Marín, J. D. Ringe et al. · Journal of Bone and Mineral Research · 2013 · 173 citations · Full text

, , +17

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

J. D. Ringe, H. Faber, P. Farahmand et al. · Rheumatology International · 2005 · 170 citations

, , +11

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study

J. D. Ringe, P. Farahmand, H. Faber et al. · Rheumatology International · 2008 · 98 citations

, , +11

Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)

J. D. Ringe, P. Farahmand, E. Schacht et al. · Rheumatology International · 2007 · 67 citations

, , +15

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

P. Farahmand, Fernando Marín, Federico Hawkins et al. · Osteoporosis International · 2013 · 46 citations · Full text

, , +17

1–5 of 11